215 related articles for article (PubMed ID: 30914223)
1. Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
Wedlock PT; Mitgang EA; Oron AP; Hagedorn BL; Leonard J; Brown ST; Bakal J; Siegmund SS; Lee BY
Vaccine; 2019 Apr; 37(17):2356-2368. PubMed ID: 30914223
[TBL] [Abstract][Full Text] [Related]
2. The value of tailoring vial sizes to populations and locations.
Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
[TBL] [Abstract][Full Text] [Related]
3. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
[TBL] [Abstract][Full Text] [Related]
4. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.
Haidari LA; Wahl B; Brown ST; Privor-Dumm L; Wallman-Stokes C; Gorham K; Connor DL; Wateska AR; Schreiber B; Dicko H; Jaillard P; Avella M; Lee BY
Vaccine; 2015 Jun; 33(28):3242-7. PubMed ID: 25889160
[TBL] [Abstract][Full Text] [Related]
5. Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.
Wallace AS; Willis F; Nwaze E; Dieng B; Sipilanyambe N; Daniels D; Abanida E; Gasasira A; Mahmud M; Ryman TK
Vaccine; 2017 Dec; 35(48 Pt B):6751-6758. PubMed ID: 29066189
[TBL] [Abstract][Full Text] [Related]
6. Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.
Lee BY; Brown ST; Haidari LA; Clark S; Abimbola T; Pallas SE; Wallace AS; Mitgang EA; Leonard J; Bartsch SM; Yemeke TT; Zenkov E; Ozawa S
Vaccine; 2019 Apr; 37(17):2377-2386. PubMed ID: 30922700
[TBL] [Abstract][Full Text] [Related]
7. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence.
Bawa S; Wondimu A; Postma MJ; Hutubessy R; van Hulst M
Expert Rev Vaccines; 2024; 23(1):655-673. PubMed ID: 38924461
[TBL] [Abstract][Full Text] [Related]
9. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
[TBL] [Abstract][Full Text] [Related]
10. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.
Krudwig K; Knittel B; Karim A; Kanagat N; Prosser W; Phiri G; Mwansa F; Steinglass R
Vaccine; 2020 Aug; 38(37):5905-5913. PubMed ID: 32703746
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
12. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
[TBL] [Abstract][Full Text] [Related]
13. An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China.
Zeng Y; Luo M; Chen J; He H; Deng X; Xie S; Fang Y
Vaccine; 2019 May; 37(23):3071-3077. PubMed ID: 31040084
[TBL] [Abstract][Full Text] [Related]
14. Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination.
Gastañaduy PA; Goodson JL; Panagiotakopoulos L; Rota PA; Orenstein WA; Patel M
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S420-S428. PubMed ID: 34590128
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
16. Assessment of vaccine wastage rates, missed opportunities, and related knowledge, attitudes and practices during introduction of a second dose of measles-containing vaccine into Cambodia's national immunization program.
Wallace AS; Krey K; Hustedt J; Burnett E; Choun N; Daniels D; Watkins ML; Soeung SC; Duncan R
Vaccine; 2018 Jul; 36(30):4517-4524. PubMed ID: 29907485
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
[TBL] [Abstract][Full Text] [Related]
19. Vaccine wastage in Ghana, Mozambique, and Pakistan: An assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage.
Mvundura M; Ng J; Reynolds K; Theng Ng Y; Bawa J; Bambo M; Bonsu G; Payne J; Chua J; Guerette J; Odei Antwi-Agyei K; Ribe S; Chinavane D; Arhin-Wiredu K; Shah A; Sitoe J; Yunus S; Powelson J; Amponsa-Achiano K; Eshioramhe Kojak K; Fredick Dadzie J; Asghar N; Caetano Correa G; Robertson J
Vaccine; 2023 Jun; 41(28):4158-4169. PubMed ID: 37270365
[TBL] [Abstract][Full Text] [Related]
20. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
